Stridespharmascience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stridespharmascience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stridespharmascience Today - Breaking & Trending Today

Strides Pharma Science Ltd recommends final dividend of Rs. 1.50

The Board of Directors of Strides Pharma Science Ltd at their meeting held on May 25, 2023, have approved the recommendation of final dividend of Rs. 1.50/- per equity share of Rs. 10/- each i.e., 15% for financial year ended March 31, 2023. ....

Strides Pharma Science , Strides Pharma Science Ltd , Annual General Meeting , Strides Pharma Science Limited ,

Strides Pharma Science Ltd Q4 FY23 consolidated loss at Rs. 9.54 crores

The Board of Directors of Strides Pharma Science Limited, at its meeting held today have approved the financial results of the company for the period ended March 31, 2023 - Q4FY23 and FY2023. ....

Strides Pharma Science , Strides Pharma Science Ltd , Pharma Science Limited , Year Ended , Financial Year , Strides Pharma Science Limited ,

Strides and Orbicular enter into a strategic partnership to jointly develop a range of nasal sprays

Strides Pharma Science Ltd and Orbicular Pharmaceutical Technologies Pvt Ltd today informed that they have entered into a strategic partnership to develop, manufacture and commercialize nasal sprays for the global markets. ....

Chestnut Ridge , New York , United States , Strides Pharma Science , Nendo Inc , Orbicular Pharmaceutical Technologies Private Limited , Strides Pharma Science Ltd , Strides Or Company , Drug Enforcement Administration , Pharma Science Ltd , Complex Injectables , Nasal Spray , Strides Pharma Science Limited ,

Strides flagship facility in Bangalore receives USFDA inspection closure

Strides Pharma Science Ltd has announced that the USFDA today issued an Establishment Inspection Report in relation to the inspection of the Company s flagship facility in Bangalore, India. ....

Strides Pharma Science Ltd , Strides Pharma Science , Drug Administration , Strides Or Company , Pharma Science Ltd , Establishment Inspection Report , Strides Pharma Science Limited ,

Strides Pharma Science Ltd Q3 FY2023 consolidated loss at Rs. 80.02 crores

The Board of Directors of Strides Pharma Science Limited, at its meeting held today have approved the financial results of the company for the period ended December 31, 2022 - Q3FY23 and 9MFY23. ....

Strides Pharma Science Ltd , Strides Pharma Science , Pharma Science Limited , Strides Pharma Science Limited ,